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13C-MR Hyperpolarization of Lactate using ParaHydrogen and 
metabolic transformation in vitro.  
Dr. E. Cavallari,[a] Dr. C. Carrera,[a] Prof. S. Aime,[a,b] Dr. F. Reineri *[a] 
 
Abstract: Hyperpolarization of the 13C magnetic resonance signal of 
L-[1-13C]Lactate has been obtained using the chemically based, 
cost-effective method named ParaHydrogen Induced Polarization 
by means of Side Arm Hydrogenation (PHIP-SAH). Two ester 
derivatives of lactate have been tested and the factors that 
determine the polarization level on the product have been 
investigated into details. The metabolic conversion of hyperpolarized 
L-[1-13C]Lactate into Pyruvate has been observed in vitro using 
lactate dehydrogenase (LDH) and in a cells lysate. From the 
acquisition of a series of 13C-NMR spectra, the metabolic build-up of 
the [1-13C]Pyruvate signal has been observed. These studies 
demonstrate that, even if the experimental set-up used for these 
PHIP-SAH hyperpolarization studies is still far from optimal, the 
attained polarization level is already sufficient to carry out in vitro 
metabolic studies.  
Introduction 
The observation that the parahydrogen spin order can be 
exploited to obtain magnetic resonance hyperpolarized signals is 
a relatively recent one.[1] Since the early studies, the application 
of this easy to handle and cost effective hyperpolarization 
methodology evolved quickly to the first in vivo studies carried 
out using 13C hyperpolarized tracers,[2] for which more than 20% 
hyperpolarization was claimed. The parahydrogen spin order is 
transformed into MR hyperpolarization when the two protons are 
added pairwise to an unsaturated bond so that their chemical 
equivalence is lost. On this basis, the applicability of 
parahydrogen as hyperpolarization tool appeared to be limited to 
molecules for which a de-hydrogenated precursor would have 
been available.  
Conversely, dissolution-Dynamic Nuclear Polarization (d-DNP)[3] 
is a hyperpolarization method that does not suffer from 
limitations regarding the hyperpolarization substrates, albeit it 
requires sophisticated and expensive instrumentation. The 
possibility to obtain hyperpolarized metabolites by means of 
DNP gathered a great deal of interest in the investigation of 
metabolic transformations in vivo.[4] It has been suggested that 
monitoring the metabolic signatures of 13C hyperpolarized 
molecules may allow to discriminate healthy from malignant 
tissues,[5] to probe the disease aggressiveness and early detect 
the response to treatment.[6] Thanks to their potential clinical role, 
these studies quickly evolved from the first in-vivo studies to pre-
clinical research and clinical trials.[7] 
The availability of this powerful tool for metabolic 
investigation is strongly limited by the high cost of the DNP 
polarizer.  The recent introduction of the so called PHIP-SAH 
strategy[8] allowed to significantly extend the applicability of 
parahydrogen to metabolites (e.g. to pyruvate) that were before 
not amenable to this hyperpolarization method. The SAH 
strategy relies on the functionalization of the molecule of interest 
(a carboxylate containing molecule) with an unsaturated alcohol 
(the “side arm”). The unsaturated bond on the alcoholic moiety 
of the ester is hydrogenated using para-enriched hydrogen and 
the non-equilibrium spin states population is transferred from 
parahydrogen protons to the 13C carboxylate by means of the 
application of a magnetic field cycle (MFC).[9] In practice, in 
PHIP-SAH, the 13C atom is hyperpolarized by the parahydrogen 
protons three and four (or four and five) bonds away using 3JH13C 
and 4JH-13C (or 4JH-13C and 5JH-13C ) instead of 2JH-13C  and 3JH-13C in 
traditional PHIP  approach.  
In principle, one may think of the use of hyperpolarized 
esters in in vivo studies, as it has been reported in brain studies, 
thanks to the ability of neutral esters to cross the lypophilic 
blood-brain barrier.[10] A more general approach relies on the 
removal of the hydrogenated side-arm by means of hydrolysis to 
obtain the free carboxylate containing compound.  
PHIP-SAH methodology is currently in its infancy and needs 
optimization of various steps in order to improve the final level of 
attainable polarization. However it may represent a real 
breakthrough in the field of metabolic imaging studies since the 
cost effective, easy to implement parahydrogen based 
hyperpolarization method would contribute to a much wider 
applicability of 13C MR hyperpolarized probes to metabolic 
imaging studies. 
Although most of the metabolic studies using 13C 
hyperpolarized tracers have been carried out using DNP 
polarized [1-13C]Pyruvate, it has been shown that L-[1-
13C]Lactate may offer some advantages.[11] Pyruvate and lactate 
are mutually converted by the lactate dehydrogenase enzyme 
(LDH) and a large pool of lactate is usually observed in tumours 
compared to that of pyruvate. Therefore, lactate can be injected 
at nearly physiological concentration (in the mM range)[11] while 
the concentration of hyperpolarized pyruvate used in these 
experiments has to be much higher than the physiological 
values. The lactate derivative 1-13C phospholactate has been 
previously hyperpolarized using parahydrogen[12] showing a 
good performance also in vivo experiments. [13]  Herein we show 
that it is possible to go straight to 13C hyperpolarized L-lactate by 
the PHIP-SAH route. 
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Results and Discussion 
Two esters, vinyl and propargyl L-lactate (scheme 1) have been 
synthesized and reacted with parahydrogen under the same 
conditions in order to test the hydrogenation yields and the 1H 
hyperpolarization. Hydrogenation of the substrates (80mM 
methanol-d4 solution) has been carried out in NMR tubes, using 
[RhCOD(ddpb)][BF4] (5mM) as catalyst (see S.I. for details).   
 
 
Scheme 1. Ester derivatives of L-lactate: 1) vinyl lactate; 2) propargyl lactate. 
1H HYPERPOLARIZATION  
Whereas the complete trasformation of the vinyl to ethyl 
ester has been observed, the hydrogenation of the triple bond 
proceeds, in part, to the full reduction of the alcoholic moiety. 
This is in accordance with the expectations that the 
hydrogenation of a triple bond is easier than that of a double one, 
therefore higher concentrations of the substrate have to be used 
under the applied reaction conditions (figure 1c and 1d).   
 
 
Figure 1. a) 1H-NMR hyperpolarized spectrum obtained from the ALTADENA 
hydrogenation of 1 and b) after relaxation. c) 1H-NMR after ALTADENA 
hydrogenation of 3 and d) at thermal equilibrium. Some residual substrate can 
be observed (peaks indicated with the asterisk) since higher amount of 
substrate was used (100mM) in order to prevent the formation of the 
completely hydrogenated alcohol.    
In order to evaluate the efficiency of singlet state transfer 
from parahydrogen to the product, ALTADENA experiments 
have been carried out and 1H NMR spectra have been acquired. 
In these experiments, the parahydrogen spin order is converted 
into 1H net magnetization during the adiabatic passage from 
earth’s field, where the hydrogenation reaction occurs, to the 
high field of the NMR magnet.[14] It has been observed (table 1) 
that, upon parahydrogenation of the vinyl ester, the polarization 
on the aliphatic signals is 2.6 -3.4%. If the propagyl ester is 
hydrogenated using parahydrogen, the olefinic signal Ha shows 
7% polarization while 3% is obtained on the methylenic protons 
(Hd protons). This observation is also consistent with the fact 
that triple bonds are hydrogenation faster than double, and 
brings the important caveat that hydrogenation intermediates for 
substrate 2 have shorter lifetimes. As a consequence  the 
singlet-triplet mixing on intermediates, i.e. mixing between the 
pure singlet state of parahydrogen with the triplet state, has a 
smaller effect on the polarization level of the product.[15] 
In order to have some clue about the polarization loss that 
occurs during the hydrogenation reaction, the parahydrogen 
percentage in the NMR tubes has been measured, after 
hydrogenation, according to the method described by Feng et al. 
(details in the S.I.).[17] It has been observed that, after that the 
parahydrogenation reaction is completed, the parahydrogen 
percentage left in the NMR tubes is about 45-50% thus 
indicating that a large percentage of parahydrogen is converted 
to orthohydrogen. Therefore the maximum theoretical 
polarization is considerably lowered from the initial 90% (with 
92% para enrichment) to about 30%. The parahydrogen 
relaxation might be due to the interaction of the H2 molecules 
with paramagnetic impurities in the hydrogenation mixture. The 
acquisition of an EPR spectrum allowed to clearly identify the 
presence of paramagnetic species (see S.I.). Those impurities 
might derive from partial catalyst degradation, therefore use of 
lower concentration and more stable catalysts may allow to 
reduce these species. Furthermore, the application of a reactor 
in which the hydrogenation mixture (catalyst and substrate) is 
sprayed into a large parahydrogen volume[18] would also 
minimize parahydrogen relaxation and increase the 
hyperpolarization on products. 
 
13C HYPERPOLARIZATION 
 
Hyperpolarization of the 13C carboxylate signal depends on  
the efficiency of singlet state addition to the product and on the 
efficiency of polarization transfer from parahydrogen to 13C. It 
has been shown that magnetic field cycle (MFC) allows this 
polarization transfer even in the case of  small J couplings 
between parahydrogen protons and the target 13C.[9a] Following 
to the application of the same MFC profile to the vinyl and to the 
propargylic ester, the 13C hyperpolarization is the same (2-2.5%) 
on the two products. One may note that the polarization of 
protons that are three bonds away from the carboxylate, i.e. the 
aliphatic protons Ha of ethyl ester (3.4%) and the methylenic 
protons of the allyl ester (Hd, 3%), is almost completely 
transferred to the 13C carboxylate. Conversely, hyperpolarization 
of the vinyl proton Ha of the allyl ester, that is coupled to the 13C 
carboxylate through a 4J coupling, is higher (7%). On the basis 
of this observation, the MFC profile has been modified in order 
to facilitate the polarization transfer through smaller J couplings 
and further increase the polarization level on the 13C signal of 
the propargylic ester.   
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Table 1. 1H polarization observed in ALTADENA experiments upon 
parahydrogenation of 1 and 2 and 13C polarization after the application of 
MFC.  
 Ha  Hb  Hd  13C  
Ethyl-lactate 3.4±0.1%  2.6±0.1 % - 2.0±0.1% [a] 
Allyl-lactate  
Allyl lactate  
7±0.5 % 4±0.5 % 3±0.5 % 2.5±0.5 % [a] 
4.5±0.5 % [b] 
[a] 13C hyperpolarization obtained using the same magnetic field cycle 
(exponential remagnetization) on both esters and [b] using slower 
remagnetization on allyl ester (13C-NMR in the SI). 
It must be considered that the J coupling between Ha (on the 
allyl ester) and the 13C carboxylate nucleus is <1Hz while the 
corresponding J with the methylenic protons is 3.2 Hz. Since 1H-
13C isotropic mixing is achieved when  ∆𝜈𝐻−𝐶~𝐽𝐻−𝐶 , the passage 
between strong to weak coupling that occurs during the 
adiabatic passage is achieved at lower magnetic field in the 
case of the allyl proton Ha in respect to the ethyl or methylene 
ones. Furthermore, for the adiabaticity criterion,[19] the minimal 
time compatible with adiabatic switching, for an AB two spin 
system, is roughly given by 1/JAB, therefore the remagnetization 
passage must be slowed down in order to facilitate the 
polarization transfer from the olefinic proton Ha to the target 13C 
carboxylate. On this basis, the remagnetization step has been 
carried out between 25nT ( ∆𝜈𝐻−𝐶~0.8 𝐻𝑧 ) and 500nT 
(∆𝜈𝐻−𝐶~ 16 𝐻𝑧 ) in 5”. It has been experimentally found that, 
when the passage from 25nT to 500nT occurs in 5”, 13C 
polarization is increased to 4.5%.  
 
13C HYPERPOLARIZED L-[1-13C]LACTATE 
The use of vinyl lactate would allow to obtain an ethyl ester, 
that is more bio-compatible than the allyl ester derived from 
hydrogenation of the propargyl derivative. Hepatotoxicity of allyl 
esters has been shown[20] under repeated oral administration of  
allyl acetate 100mg/kg in rats (LD50 in rats 130mg/Kg), therefore 
the use of vinylated esters is more advisable.[21]  
In the present work, on the basis of the observed 
polarization, propargyl lactate has been chosen for the 
generation of hyperpolarized L-[1-13C]Lactate.  
In order to obtain a hyperpolarized metabolite suitable for in 
vivo studies, an aqueous solution is needed, without the 
hydrogenation complex. The use of a supported catalyst would 
allow to obtain complete removal of the toxic metal from the 
solution of the hyperpolarized product and to recover the 
expensive catalyst, and the development of these catalysts will 
be an important step towards the clinical translation 
perspective.[22] In this work, the phase transfer method has been 
applied.[23] According to this procedure, the lipophylic substrate is 
hydrogenated in an organic, hydrophobic solvent, (e.g. 
chloroform/methanol or chloroform/ethanol mixture 5/1). Then an 
aqueous base (NaOH) is quickly added to the organic phase in 
order to attain the hydrolysis of the ester and the extraction of 
the hydrophilic carboxylate-containing compound in the aqueous 
phase, while the metal complex is retained in the organic phase. 
Hydrolysis of the allyl ester has been obtained using a 
aqueous solution of sodium hydroxide (NaOH 100 mM) and 
sodium ascorbate (50 mM). The latter acts as a scavenger of 
paramagnetic impurities.[24] Using a homemade set-up, the 
aqueous base has been pressurized (3bar), heated (350K) and 
injected into the NMR tube containing the hyperpolarized ester. 
An emulsion of the two phases is instantaneously formed and, 
following to the addition of an acidic buffer (HEPES 100mM, pH 
6), the physiological pH has been reached (pH 7±0.5). The 
separation of the two phases is quick (3-4”). Then the upper 
aqueous solution, containing the hyperpolarized metabolite 
(60±10mM), has been transferred into a NMR tube for the 
acquisition of the 13C-NMR spectra (figure 2).  
 
 
Figure 2. a) 13C-NMR spectrum of 13C labelled 2 after hydrogenation with 
parahydrogen and application of magnetic field cycle (ethanol/CDCl3 = 1/5); b) 
13C-NMR of hyperpolarized L-[1-13C]-Lactate obtained after the hydrolysis of 
the ester.  
 
The polarization level observed on the 13C signal of the 
product is 2.9±0.2 % (corresponding to S.E. 2400 ± 200 at 
14.1T) and the concentration is 50±10mM (see figure S9). 
Overall, the hydrolysis work-up takes approximately 40s during 
which a substantial loss of polarization takes place 
(hyperpolarization decays towards the thermal equilibrium with a 
rate dictated by the T1 of the [1-13C]lactate signal in the aqueous 
solution).  Being the whole process carried out manually, this 
time might be dramatically reduced, e.g. to 10-20”, when a 
dedicated automatized set-up will be available. In order to be 
able to back-calculate the initial 13C hyperpolarization, the 
longitudinal relaxation time constant (T1) at earth’s field has 
been evaluated. The time delay after hydrolysis (t) has been 
gradually increased and 13C signal enhancement has been 
measured on different samples, at increasing t (see S.I.). It is 
found that T1= 40±1s and the polarization level, back-calculated 
at time zero, is 7.9±0.4%. 
 
METABOLIC TESTS 
The metabolic transformation of the hyperpolarized L-[1-
13C]Lactate into [1-13C]Pyruvate has been tested using a 
buffered solution of LDH, NAD+/NADH and Sodium pyruvate. 
The enzyme solution has been placed into a 10mm NMR tube 
inside the NMR spectrometer (14.1T), with one connecting inlet 
line for the perfusion of the hyperpolarized metabolite, and kept 
at 310K. After hyperpolarization and hydrolysis of the ester, part 
of the aqueous phase (150ul) has been collected into a syringe, 
diluted with a buffered solution of pyruvate (350ul HEPES 
solution, final concentration of pyruvate 1 mM) and injected, 
through the inlet line, into the enzyme-containing solution. After 
mixing of the hyperpolarized metabolite a series of small flip 
angle 13C NMR spectra has been acquired from which the 
metabolic build-up of [1-13C]pyruvate can be clearly observed 
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(figure 3). The concentration of L-[1-13C]Lactate in the final 
solution was determined (4±1 mM) by adding 13C-enriched urea 
(3mM) as an internal reference (see figure S10).  
 
 
Figure 3. Series of 13C-NMR spectra (~15° pulses) acquired following to the 
perfusion of [1-13C]lactate, hyperpolarized by means of PHIP-SAH, to an 
aqueous solution of LDH (HEPES solution containing NAD+/NADH). b) time-
dependent signal intensity of [1-13C]lactate (filled dots) and [1-13C]pyruvate 
(open triangles).  
The possibility of following metabolic transformation has also 
been tested on breast cancer (TS/A)[25] lysed cells. Cells (2*107) 
have been harvested from the growing plate, washed once with 
their growing medium and lysed. Then the growing medium 
(1ml) has been added, the solution has been transferred in the 
NMR tube and the same experiment used for the enzyme-
containing solution has been carried out. A low level of [1-
13C]Pyruvate can be detected, which is consistent with what 
observed using DNP hyperpolarized lactate.[11] In fact the 
sensitivity of the measurement of LDH activity obtained from the 
exchange between L-[1-13C]lactate and endogenous pyruvate is 
much smaller than that of the exchange between [1-13C]pyruvate 
and endogenous lactate.[11b] However the advantages 
associated to the use of lactate for in vivo studies have been 
demonstrated using H/D exchange on L-[1-13C,U-2H]Lactate. [11b] 
 
Figure 4. Series of 13C-NMR spectra (~15° pulses) acquired following to the 
perfusion of [1-13C]lactate, hyperpolarized by means of PHIP-SAH, to a cells 
lysate (20*106 TSA cells) dissolved in the cells grow medium (1ml RPMI). 
 
 
 
Conclusions 
An aqueous solution of hyperpolarized L-[1-13C]Lactate, 
suitable for in vitro metabolic studies, has been obtained by 
means of the PHIP-SAH method. The potential main factors that 
determine the polarization level on the end product have been 
investigated, namely the efficiency of the singlet state transfer to 
the hydrogenation product and the polarization transfer from 
parahydrogen protons to the target 13C carboxylate signal. It has 
been observed that the polarization level on protons, in 
ALTADENA experiments, is significantly lower than the 
theoretical maximum expected using 90% enriched 
parahydrogen. In separate experiments, parahydrogen 
relaxation in the NMR tube, following to hydrogenation, has 
been measured and it has been observed that a large part of 
parahydrogen is converted into orthohydrogen during the 
hydrogenation reaction in the NMR tube. This phenomenon is 
likely due to the interaction between parahydrogen and 
paramagnetic impurities in the hydrogenation mixture. A 
considerable increase of the polarization level can be predicted, 
following to removal of these radicals and use of a  
hydrogenation reactor. A tailored magnetic field cycle profile has 
been used in order to increase the polarization transfer from the 
most polarized proton of the propagyl derivative to the target 
13C carboxylate signal. This allowed to observe 𝑃 𝐶13 = 4.8% on 
the parahydrogenated allyl-lactate. Albeit the polarization level is 
not optimized yet, it has been shown that it is well sufficient for 
carrying out in vitro metabolic studies. 
Experimental Section 
Hydrogenation reactions have been carried out into NMR tubes equipped 
with gas-tight teflon valve. Before hydrogenation of the substrate, the 
catalyst [1,4-Bis(diphenylphosphino)butane](1,5-cyclooctadine)Rh(I) 
tetrafluoroborate (1mmol, Sigma-Aldrich, CAS 70255-71-3, part n 
341134) has been activated through hydrogenation of the coordinated 
diene. After that the catalyst has been completely dissolved in the 
organic solvent (methanol-d4), the substrate has been added, the NMR 
tube has been pressurized with 8 bar of hydrogen enriched in the para 
isomer (92% enrichment) and the reaction has been started by shacking 
the NMR tube for 5s at 350K. 
In the phase extraction experiments, the Rh(I) catalyst has been 
activated in 30ul of ethanol, then, after that the complex has been 
dissolved, a chloroform solution of the substrate (240mM) has been 
added and the hydrogenation with parahydrogen has been carried out as 
reported above. More experimental details are described in the S.I.   
Magnetic field cycle has been applied using a mu-metal chamber (triple 
shield) that allows to shield the earth’s magnetic field and to obtain 25nT 
in the most shielded part of the chamber. A coil fed with current (Agilent 
arbitrary waveform generator 33220A) electronically controlled by a 
custom written function has been placed into the shield. The magnetic 
field cycle device has been provided by Aspect Imaging (IL). 
For enzymatic reaction experiment, an aqueous solution (1ml) of 1mg of 
LDH, (about 600U) (Sigma-Aldrich L-Lactic Dehydrogenase from rabbit 
muscle part n.1254-25KU) NAD+ (1mM, Sigma-Aldrich B-nicotinamide 
Adenine dinucleotide N7004) and NADH (0.5mM Sigma-Aldrich B-NAD 
reduced form disodium N6660-15VL) has been prepared in HEPES 
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buffer. The and sodium pyruvate (1mM) in a buffer medium (HEPES 
40mM) have been used. More details about the experiments with cells 
lysate in the S.I. The concentration of the hyperpolarized [1-13C]lactate in 
the aqueous mixture, after dilution, was 4±1 mM, the total volume was 
1.5ml. 
All the NMR spectra have been acquired using a 14T Bruker Avance 
NMR spectrometer. 
Parahydrogen has been obtained using the Bruker ParaHydrogen 
Generator (BPHG). 
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FULL PAPER    
 
 
 
 
 
 
 
FULL PAPER 
The hyperpolarization method 
ParaHydrogen Induced Polarization 
by means of Side Arm 
Hydrogenation has allowed to obtain 
a bio-compatible aqueous solution of 
13C-MR hyperpolarized L-[1-
13C]lactate. The metabolic 
conversion of the hyperpolarized 
product into [1-13C]pyruvate, 
catalyzed by the enzyme lactate 
dehydrogenase, has been observed 
by acquiring a series of 13C-NMR 
spectra (see figure). 
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